University of California, San Diego joins PPMI as a clinical site

The PPMI Steering Committee has recently selected the University of California, San Diego as a PPMI clinical site. Dr. Douglas Galasko will be the Principal Investigator of this site.  The site was approved after meeting all of the study steering committee’s requirements, including having the necessary technological expertise and significant experience recruiting subjects for Parkinson?s Disease studies ? two key factors in the success of a site in PPMI.

UCSD is beginning to prepare the regulatory submission for the study. The site is expected to be activated in Spring 2011.